AbbVie has decided against progressing a recommendation by the Pharmaceutical Benefits Advisory Committee for the listing of VENCLEXTA (venetoclax). …
Latest Video
New Stories
-
The commercialisation of NPS MedicineWise
September 24, 2018 - - Latest News -
UK industry slams court decision on unapproved use
September 24, 2018 - - Latest News -
The challenge for an 'evolving' organisation
September 24, 2018 - - Comment -
OPDIVO secures approval for 11th indication
September 24, 2018 - - Latest News -
GSK and MMV announce KOZENIS approval
September 24, 2018 - - Latest News -
Government to review NPS MedicineWise
September 21, 2018 - - Latest News -
Medicines NZ 2018 Value of Medicines Award
September 21, 2018 - - Latest News